Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Irinotecan Impurity 8

Irinotecan Impurity 8 is listed in the pharmaceutical impurity collection under CAS 936348-90-2. Its represented structure has formula C6H10ClNO2 and a calculated molecular weight of 163.60 g/mol.

2D chemical structure

O C l N H O

Chemical identity

Catalog name
Irinotecan Impurity 8
Common name
Irinotecan Impurity 8
Chemical name
4-hydroxypiperidine-1-carbonyl chloride
CAS
936348-90-2
SMILES
O=C(Cl)N1CCC(O)CC1
InChI
InChI=1S/C6H10ClNO2/c7-6(10)8-3-1-5(9)2-4-8/h5,9H,1-4H2
InChIKey
KICLWTGYAPUGKT-UHFFFAOYSA-N
Associated API
Irinotecan

Record ID: Aee7826550fa9

Computed properties

C6H10ClNO2 Molecular formula
163.604 g/molMolecular weight
163.04 DaMonoisotopic exact mass
40.54 ŲTopological polar surface area
0.8019 Calculated LogP (Wildman–Crippen)
38.0628 cm³/molMolar refractivity (Wildman–Crippen)
2 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 2 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H N O 0 3 6 9 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight163.6048.64
Calculated LogP (Wildman–Crippen)0.801922.50
Topological polar surface area40.5422.55
Hydrogen-bond acceptors215.92
Hydrogen-bond donors138.08
Rotatable bonds (strict)03.45

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC6H10ClNO2dimensionless
Molecular weight163.604g/mol
Monoisotopic exact mass163.04Da
Topological polar surface area40.54Ų
Calculated LogP (Wildman–Crippen)0.8019dimensionless
Molar refractivity (Wildman–Crippen)38.0628cm³/mol
Hydrogen-bond acceptors2count
Hydrogen-bond donors1count
Rotatable bonds (strict)0count
Heavy atoms10count
Heteroatoms4count
Rings1count
Aromatic rings0count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles0count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles0count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.8333fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area64.577Ų
Valence electrons58count
Radical electrons0count
Bertz complexity131.7095index
Balaban J2.3282index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Irinotecan Impurity 8

Qualification and safety assessment of Irinotecan Impurity 8

Explore toxicological qualification of Irinotecan Impurity 8 and ICH M7 mutagenic impurity assessment of Irinotecan Impurity 8 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Irinotecan Impurity 8 and acceptable intake and limit justification for Irinotecan Impurity 8. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Irinotecan Impurity 8

Explore Altox services and software through the Altox Pharma-Hub.